- Home
- WRBY vs TARS Comparison
WRBY vs TARS Comparison
Compare WRBY & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRBY
- TARS
- Stock Information
- Founded
- WRBY 2010
- TARS 2016
- Country
- WRBY United States
- TARS United States
- Employees
- WRBY N/A
- TARS N/A
- Industry
- WRBY Ophthalmic Goods
- TARS Medicinal Chemicals and Botanical Products
- Sector
- WRBY Health Care
- TARS Health Care
- Exchange
- WRBY Nasdaq
- TARS Nasdaq
- Market Cap
- WRBY 3.5B
- TARS 2.8B
- IPO Year
- WRBY 2021
- TARS 2020
- Fundamental
- Price
- WRBY $19.59
- TARS $68.81
- Analyst Decision
- WRBY Buy
- TARS Strong Buy
- Analyst Count
- WRBY 16
- TARS 7
- Target Price
- WRBY $25.13
- TARS $69.43
- AVG Volume (30 Days)
- WRBY 1.9M
- TARS 560.5K
- Earning Date
- WRBY 11-06-2025
- TARS 11-04-2025
- Dividend Yield
- WRBY N/A
- TARS N/A
- EPS Growth
- WRBY N/A
- TARS N/A
- EPS
- WRBY N/A
- TARS N/A
- Revenue
- WRBY $821,347,000.00
- TARS $295,521,000.00
- Revenue This Year
- WRBY $17.16
- TARS $139.46
- Revenue Next Year
- WRBY $14.75
- TARS $49.91
- P/E Ratio
- WRBY N/A
- TARS N/A
- Revenue Growth
- WRBY 14.09
- TARS 254.45
- 52 Week Low
- WRBY $13.63
- TARS $38.51
- 52 Week High
- WRBY $29.73
- TARS $76.81
- Technical
- Relative Strength Index (RSI)
- WRBY 23.92
- TARS 56.95
- Support Level
- WRBY $19.01
- TARS $66.31
- Resistance Level
- WRBY $22.64
- TARS $74.83
- Average True Range (ATR)
- WRBY 0.86
- TARS 2.81
- MACD
- WRBY -0.19
- TARS -0.84
- Stochastic Oscillator
- WRBY 16.12
- TARS 30.50
About WRBY Warby Parker Inc.
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.